Testosterone hydroxylase as multibiomarker of effect in evaluating vinclozolin cocarcinogenesis

Biomarkers

Volumn 3, Issue 3, 1998, Pages 191-203

  Paolini, Moreno ^a   Pozzetti, Laura ^a   Sapone, Andrea ^b   Camerino, Alessandro ^a   Cantelli Forti, Giorgio ^a,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cocarcinogenesis; Glutathione S transferase; Testosterone hydroxylase; Vinclozolin

Indexed keywords

BIOCHEMICAL MARKER; DRUG METABOLITE; FUNGICIDE; GLUTATHIONE TRANSFERASE; OXYGENASE; TESTOSTERONE; TESTOSTERONE DERIVATIVE; TESTOSTERONE HYDROXYLASE; UNCLASSIFIED DRUG; VINCLOZOLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCARCINOGENESIS; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG METABOLISM; FEMALE; KIDNEY MICROSOME; LIVER MICROSOME; LUNG; MALE; MOUSE; NONHUMAN;

ANIMALIA;

EID: 0031801579     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/135475098231219     Document Type: Article

References (40)

1. ASHBY, J. 1994, Use of short-term tests in determining the genotoxicity or nongenotoxicity of chemicals. In Mechanisms of Carcinogenesis in Risk Identification, H. Vainio, P. N. Magee, D. B. McGregor, and A. J. McMitchael, eds (Lyon: International Agency for Research on Cancer), pp. 135-164.
2. BAILEY, L. 1967, Techniques in Protein Chemistry (Amsterdam: Elsevier), pp. 340-341.
3. BAST, A. 1986, Is formation of reactive oxygen by cytochrome P450 perilous and predictable? Trends in Pharmacological Sciences, 7, 226-227.
4. BOX, G. E. P. and HUNTER, W. G. 1978, Statistics for Experiments (New York: Wiley), pp. 80-82.
5. BUTTERWORTH, B. E. 1990, Consideration of both genotoxic and non-genotoxic mechanisms in predicting cocarcinogenic potential. Mutation Research, 239, 117-132.
6. CERUTTI, P. A. 1985, Prooxidant states and tumor promotion. Science, 227, 375-381.
7. CHIESARA, E., ARNOLDI, A., COVA, D. and RIZZI, R. 1982, Detection of mutagenicity of vinclozolin and its epoxide intermediate. Archives of Toxicology, Supplement, 5, 345-348.
8. CLARK, T. 1983, The stability of vinclozolin in the presence of ethanol, methanol and water. Chemosphere, 12, 1363-1369.
9. CONWAY, J. G., CATTLEY, R. C., POPP, J. A. and BUTTERWORTH, B. E. 1990, Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate Drug Metabolism Reviews, 21, 65-102.
10. ENVIRONMENTAL PROTECTION AGENCY (US EPA) 1985, Peer Review of Ronilan (Vinclozolin), Caswell No. 323C. Toxicological Review 004894, June 17.
11. ENVIRONMENTAL PROTECTION AGENCY (US EPA) 1987, Ronilan Fungicide-EPA registration No. 7969-53. Tox. Chem. No. 323C. Toxicological Review 005853, April 24.
12. GEORGOPOULOS, S. G., SARRIS, M and ZIOGAS, B. N. 1979, Mitotic instability in Aspergillus nidulans caused by the fungicides iprodione, procymidone and vinclozolin. Pesticide Science, 10, 389-392.
13. HABIG, W. H., PABST, M. J. and JAKOBY, W. B. 1974, Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry, 249, 7130-7139.
14. HAI, A. 1991, Testing times for the tests. Nature, 350, 555-556.
15. 14C-vinclozolin. USEPA Guideline Number 85-1. Submission from BASF Corporation, MRID 418243-07.
16. HRELIA, P., FIMOGNARI, C., MAFFEI, F., VIGAGNI, F., MESIRCA, R., POZZETTI, L., PAOLINI, M. and CANTELLI-FORTI, G. 1996, The genetic and non-genetic toxicity of the fungicide vinclozolin. Mutagenesis, 11(5), 445-453.
17. IARC 1991, Mechanisms of Carcinogenesis in Risk Identification. A consensus report of an IARC monograph working group (Lyon: IARC).
18. ITO, N., HASEGAWA, R., IMAIDA, K., TAKAHASHI, S. and SHIRAI, T. 1994, Medium-term rat liver bioassay for rapid detection of carcinogens and modifiers of hepatocarcinogenesis. Drug Metabolism Reviews, 26, 431-442.
19. KELCE, W. R., MONOSSON, E., GAMSSIK, M. P., LAWS, S. C. and GRAY, E. JR. 1994, Environmental hormone disrupter: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicology and Applied Pharmacology, 126, 276-285.
20. KITCHIN, K. T., BROWN, J. L. and KULKARNI, A. P. 1993, Predicting rodent carcinogenicity of halogenated hydrocarbons by in vivo biochemical parameters Teratogenesis Carcinogenesis and Mutagenesis, 13, 67-184.
21. LITCHFIELD, J. T. and WILCOXON, F. 1987, Confidence limits of ED50. In Manual of Pharmacologic Calculations with Computer Programs, R. J. Tallaride and R. B. Murray, eds (New York: Springer Verlag), pp. 153-155.
22. LOWRY, O. H., ROSEBROUGH, H. J., FARR, A L. and RANDALL, R. J. 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
23. LUBET, R. A., DRAGNEV, K. A., CHAUHAN, D. P., NIMS, R. W., DIWAN, B. A., WARD, G. M., JONES, C. R., RICE, J. M. and MILLER, M. S. 1992, A pleiotropic response to phenobarbital type enzyme inducers in the F344/NC rat. Biochemical Pharmacology, 43, 1067-1078.
24. PAOLINI, M., BIAGI, G. L., CANTELLI-FORTI, G. and BAUER, C. 1994, Further mechanisms of non-genotoxic carcinogenesis. Trends in Pharmacological Sciences, 15, 322-323.
25. PAOLINI, M., MESIRCA, R., POZZETTI, L., SAPONE, A and CANTELLI-FORTI, G. 1995, Induction of CYP2B1 mediated pentoxyresorufin O-dealkylase activity in different species, sex and tissue by prototype 2B1-inducers. Chemical and Biological Interactions, 95, 127-139.
26. PAOLINI, M., POZZETTI, L., MESIRCA, R., SAPONE, A. and CANTELLI-FORTI, G. 1996a, Testosterone hydroxylase in evaluating induction and suppression of murine CYP isoenzymes by fenarimol. Archives of Toxicology, 70, 451-456.
27. PAOLINI, M., POZZETTI, L., PEDULLI, G. F., CIPOLLONE, M., MESIRCA, R. and CANTELLI-FORTI, G. 1996b, Paramagnetic resonance in detecting carcinogenic risk from cytochrome P450 overexpression. Journal of Investigative Medicine (Clinical Research), 44/8, 470-473.
28. PAOLINI, M., MESIRCA, R., POZZETTI, L., GIALLUCA, N., BAUER, C., BIAGI, G. L. and CANTELLI-FORTI, G. 1998, Cancer chemoprevention: some complications and limitations. Cancer Detection and Prevention, 22.
29. PLATT, J., MOLITOR, E., DOEHMER, J., DOGRA, S. and OESCH, F. 1989, Genetically engineered V79 Chinese Hamster cells. Expression of purified cytochrome P450 2B1 monooxygenase activity. Biochemical Toxicology, 4, 1-5.
30. RABBITS, T. H. 1994, Chromosomal translocation in human cancer. Nature, 172, 143-149.
31. RONIS, M. J. J., INGELMAN-SUNDBERG, M. and BADGER, T. M. 1994, Induction, suppression and inhibition of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus Virginianus) by ergosterol biosynthesis inhibiting fungicides (EBIFs). Biochemical Pharmacology, 48, 1953-1955.
32. SCHULTE-HERMANN, R., OCHS, O., BURSCH, W., and PARZEFALL, W. 1988, Quantitative structure-activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver. Cancer Research, 48, 2462-2468.
33. SHAW, I. C. and JONES, H. B. 1994, Mechanisms of non-genotoxic carcinogenesis. Trends in Pharmacological Sciences, 15, 83-93.
34. SHI, Y. E. and YAGER, J. D. 1989, Effects of the liver tumor promoter ethynil estradiol on epidermal growth factor-induced DNA synthesis and epidermal growth factor receptor levels in cultured rat hepatocytes. Cancer Research, 49, 3574-3580.
35. SZETO, S. Y., BURLINSON, N. E., RAHE, J. E. and OLOFFS, P. C. 1989a, Kinetics of hydrolysis of the dicarboximide fungicide vinclozolin. Journal of Agricultural and Food Chemistry, 37, 523-529.
36. SZETO, S. Y., BURLINSON, N. E., RAHE, J. E. and OLOFFS, P. C. 1989b, Persistence of the fungicide vinclozolin on pea leaves under laboratory conditions, Journal of Agricultural and Food Chemistry, 37, 529-534.
37. SZETO, S. Y., BURLINSON, N. E., RETTIG, S. J. and TROTTER, J. 1989c, Identification of hydrolysis products of vinclozolin by spectroscopic and X-ray crystallographic methods, Journal of Agricultural and Food Chemistry, 37, 1103-1108.
38. VALLINI, G., PERA, A., and DE BERTOLDI, M. 1983, Genotoxic effects of some agricultural pesticides in vitro tested with Aspergillus nidulans. Environmental Pollution, 30, 39-58.
39. VAN DER HOEVEN, T. H. 1984, Assay of hepatic microsomal testosterone hydroxylase by high-performance liquid chromatography. Analytical Biochemistry, 138, 57-65.
40. VAN RAVENZWAAY, B. 1992, Discussion of prenatal and reproductive toxicity of Reg. No. 83-258 (Vinclozolin). Data submission to USEPA from BASF Corporation, MRID 425813-02.